Cargando…

Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study

BACKGROUND: Recipients of living donor renal transplantation are typically considered to have a relatively lower immunological risk. This retrospective study aimed to compare the therapeutic efficacy and safety between rabbit antithymocyte globulin (rATG) or interleukin-2 receptor antagonist (IL2-RA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Jiang, Li, Jun, Chen, Guodong, Huang, Gang, Fu, Qian, Wang, Changxi, Chen, Lizhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429807/ https://www.ncbi.nlm.nih.gov/pubmed/30902050 http://dx.doi.org/10.1186/s12882-019-1293-2

Ejemplares similares

Severe Intraoperative Anaphylaxis Related to Thymoglobulin during Living Donor Kidney Transplantation
por: Saeed, Muhammad I., et al.
Publicado: (2020)

Recipient-Related Risk Factors for Graft Failure and Death in Elderly Kidney Transplant Recipients
por: Lai, Xingqiang, et al.
Publicado: (2014)

Outcomes of thymoglobulin versus basiliximab induction therapies in living donor kidney transplant recipients with mild to moderate immunological risk – a retrospective analysis of UNOS database
por: Ali, Hatem, et al.
Publicado: (2023)

Grafalon® vs. Thymoglobulin® as an Induction Agent in Renal Transplantation – A Retrospective Study
por: Jha, Pranaw Kumar, et al.
Publicado: (2021)

Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression
por: Zuckermann, Andreas, et al.
Publicado: (2015)

Thymoglobulin Versus Alemtuzumab Versus Basiliximab Kidney Transplantation From Donors After Circulatory Death
por: Asderakis, Argiris, et al.
Publicado: (2022)

Successful single kidney transplantation from pediatric donors less than or equal to 10 kg to adult recipient: a retrospective cohort study
por: Chen, Chuxiao, et al.
Publicado: (2021)

Thymoglobulin Induction Dosing Strategies in a Low-Risk Kidney Transplant Population: Three or Four Days?
por: Hardinger, Karen L., et al.
Publicado: (2010)

An avoidable cause of thymoglobulin anaphylaxis
por: Brabant, S., et al.
Publicado: (2017)

Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study
por: Heldal, Kristian, et al.
Publicado: (2013)

Post-transplant outcomes in recipients of living donor kidneys and intended recipients of living donor kidneys
por: Dharia, Atit A., et al.
Publicado: (2022)

Thymoglobulin – new approaches to optimal outcomes
por: Delia Moiceanu, Andreea, et al.
Publicado: (2009)

Long-term results of a calcineurin inhibitor-free immunosuppression based on Thymoglobulin® and mycophenolate mofetil in elderly kidney transplant recipients
por: Kamar, Nassim, et al.
Publicado: (2008)

Feasibility of conditioning with thymoglobulin and reduced intensity TBI to reduce acute GVHD in recipients of allogeneic SCT
por: Toor, A, et al.
Publicado: (2008)

Characteristics and Prognosis of Stroke in Living Donor Renal Transplant Recipients
por: Mizuno, Takafumi, et al.
Publicado: (2022)

Post-Transplant Cyclophosphamide and Thymoglobulin, a Graft-Versus-Host Disease Prophylaxis in Matched Sibling Donor Peripheral Blood Stem Cell Transplantations
por: Kunacheewa, Chutima, et al.
Publicado: (2020)

Living Donor Intestinal Transplantation: Recipient Outcomes
por: Wu, Guosheng, et al.
Publicado: (2022)

Thymoglobulin vs. ATG-Fresenius as Induction Therapy in Kidney Transplantation: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
por: Song, Turun, et al.
Publicado: (2020)

Risk of human papillomavirus infection and cervical intraepithelial lesions in Chinese renal transplant recipients
por: Chen, Ming, et al.
Publicado: (2022)

Adult Living-Donor Kidney Transplantation, Donor Age, and Donor–Recipient Age
por: Hiramitsu, Takahisa, et al.
Publicado: (2021)

Interleukin receptor antagonist induction in kidney transplantation: Is it worth the price?
por: Kher, V.
Publicado: (2013)

Living Donor Kidney Transplant in Recipients With Glomerulonephritis: Donor Recipient Biologic Relationship and Allograft Outcomes
por: El-Rifai, Rasha, et al.
Publicado: (2023)

Comparing the effect of induction therapy with or without antithymocyte globulin on renal allograft outcomes in live-donor kidney transplant recipients
por: Marghoob, Bahareh, et al.
Publicado: (2019)

Recipient Outcomes with Younger Donors Undergoing Living Donor Liver Transplantation
por: Dar, Faisal S, et al.
Publicado: (2019)

La thymoglobuline en traitement d’induction chez les transplantés rénaux à faible risque immunologique: une expérience marocaine
por: Abouzid, Zineb, et al.
Publicado: (2022)

New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin(®)) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity
por: Mohty, Mohamad, et al.
Publicado: (2014)

Evaluating graft function in pediatric recipients for living donor renal transplantation: Is laparoscopic donor nephrectomy safe?
por: Mishra, Shashikant, et al.
Publicado: (2009)

A Proposal for Early Dosing Regimens in Heart Transplant Patients Receiving Thymoglobulin and Calcineurin Inhibition
por: Barten, Markus J., et al.
Publicado: (2016)

Efficacy of basiliximab induction in poorly matched living donor renal transplantation
por: Gundlapalli, S., et al.
Publicado: (2013)

Erratum to: New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin(®)) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity
por: Mohty, Mohamad, et al.
Publicado: (2014)

Effect of donor kidney morphology parameters on the prognosis in living kidney transplantation recipients
por: Qiu, Yang, et al.
Publicado: (2020)

Tolvaptan for Fluid Management in Living Donor Liver Transplant Recipients
por: Imai, Shunichi, et al.
Publicado: (2018)

Clinical Outcomes of Tuberculosis in Recipients After Living Donor Liver Transplantation
por: Salvador, Noruel Gerard A., et al.
Publicado: (2018)

The International Liver Transplantation Society Living Donor Liver Transplant Recipient Guideline
por: Miller, Charles M., et al.
Publicado: (2017)

Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures
por: Bonanno, Giuseppina, et al.
Publicado: (2010)

Outcome of glomerulonephritis in live-donor renal transplant recipients: A single-centre experience
por: Akl, Ahmed Ibrahim, et al.
Publicado: (2015)

Quantifying infection risks in incompatible living donor kidney transplant recipients
por: Avery, Robin K., et al.
Publicado: (2020)

Varicella Infection in an Immunized Pediatric Living Donor Liver-Transplant Recipient
por: Mehta, Vibha, et al.
Publicado: (2021)

Sarcopenia adversely impacts postoperative complications in living-donor liver transplantation recipients
por: Wu, Mei-Yun, et al.
Publicado: (2021)

Effect of donor-specific antibodies and panel reactive antibodies in living donor liver transplant recipients
por: Song, Seung Hwan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ik2sdj8rhqh4affdsmbsjf22v6